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Previewssystem is maintained by stem cells with
long- and short-term regenerative poten-
tial, which are predominantly quiescent
and resistant to injury, as well as
committed multipotent, oligopotent, and
unipotent progenitors, which have in-
creased proliferative potential. Decipher-
ing how environmental and physiological
inputs regulate signaling pathways
affecting slowly and rapidly cycling ISC
populations in the niche during homeo-
stasis and pathological states such as
cancer and inflammatory bowel disease
will be important directions for future
studies.4 Cell Stem Cell 10, January 6, 2012 ª2012 EREFERENCES
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The Polycomb repressive complexes (PRC) regulate self-renewal and differentiation in embryonic stem cells
(ESCs). In this issue of Cell Stem Cell, Morey et al. (2012) and O’Loghlen et al. (2012) report that dynamic
interchange of PRC subunits modulates the balance between self-renewal and lineage commitment in
ESCs.Differentiate or self-renew? This is the
principal question faced by all stem cells.
The self-renewal of embryonic stem cells
(ESCs) is maintained through expression
of pluripotency genes and repression
of lineage-specific genes. Conversely,
differentiation is achieved through re-
pression of the genes required for plu-
ripotency, with simultaneous activation
of a cascade of lineage-specific epige-
netic and transcriptional changes. First
identified in Drosophila, the Polycomb
group (PcG) proteins are known regula-
tors of ESC differentiation and do so
by maintaining repressive chromatin
states. The mammalian genome encodes
multiple homologs of PcG components
which broadly associate in two func-
tionally distinct complexes, PRC1 and
PRC2. PRC2 has been shown to func-
tionally trimethylate lysine 27 on histoneH3 (H3K27me3), while PRC1 monoubi-
quitylates histone H2A on lysine 119
(H2AK119Ub1) (Cao and Zhang, 2004;
de Napoles et al., 2004). The prevailing
dogma posits PRC2 and PRC1 work as
a team to prevent transcription of genes
that initiate differentiation. Mechanisti-
cally this is thought to occur via a PRC2-
mediated deposition of H3K27me3
followed by H2AK119Ub1 catalyzed by
PRC1 specifically at these sites. In plurip-
otent cells, PRC1/PRC2 co-occupy
regions which overlap with H3K27me3,
and a large proportion of these sites
are proximal to genes involved in de-
velopment and lineage commitment
(Ku et al., 2008). Additionally, loss of
function of either PRC1 or PRC2 in
pluripotent cells does not affect expres-
sion of key pluripotency genes, but
rather leads to derepression of genes nor-mally upregulated during differentiation
(Chamberlain et al., 2008; Leeb and
Wutz, 2007).
Although PRC1 functionally targets
PRC2 modified chromatin, it is unclear
how PRC1 identifies sites of PRC2 cata-
lyzed H3K27me3 and what regulatory
mechanisms exist to facilitate derepres-
sion of PcG bound chromatin in response
to ESC differentiation. Unlike PRC2,
the PRC1 complex has been shown
to contain a number of Polycomb ortho-
logs (PCs) known as the Cbx family of
proteins. Cbx proteins have been shown
to interact directly with methylated
histone H3 and are enriched at sites of
heterochromatin (Bernstein et al., 2006).
While PRC1 is functionally important for
ESC self-renewal and differentiation,
there has been no clear experimental

































Figure 1. Model Illustrating the Dynamic Role of the Cbx Proteins in
PRC1 Function
(A) In pluripotent mESCs, Cbx7 is the sole PC ortholog found in the PRC1
complex. PRC1/Cbx7 repress expression of lineage-specific genes as well
as other Cbx genes (Cbx2, Cbx4, and Cbx8) via Cbx7’s specificity for PRC2
catalyzed H3K27me3.
(B) During differentiation, miR-125 and miR-181 expression is upregulated,
whileCbx7 isdownregulated. ExpressionofCbx7 isdecreasedandCbxprotein
function is directly abrogated by miR-125 and miR-181. Loss of Cbx7/PRC1-
mediated repression leads to transcriptional activation of lineage-specific
genes with a concomitant increase in expression of Cbx2, 4, and 8. Cbx2, 4,
and 8 interact with PRC1, forming new repressive complexes. These ‘‘differen-
tiation-specific’’ PRC1 complexes downregulate expression of pluripotency
genes, as well as Cbx7, contributing to a PcG autoregulatory mechanism to
further suppress self-renewal and guide the cell toward lineage commitment.
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Previewstarget selectivity (H3K27me3)
or regulation of PRC1 com-
plexes in response to
differentiation.
In this issue of Cell Stem
Cell, reports from Morey et al.
(2012) and O’Loghlen et al.
(2012) have identified novel
roles for several Cbx proteins
in maintenance of mouse
ESC (mESCs) self-renewal
and regulation of differentia-
tion. These studies begin to
unravel how PcG complexes
are functionally regulated
during ESC differentiation
and underscore the impor-
tance of Cbx proteins in tar-
geting of PRC1 to H3K27me3
in both pluripotent and differ-
entiating cells. Both Morey
et al. and O’Loghlen et al.
begin their respective studies
by identifying Cbx7 as the
primary Cbx component of
PRC1 in pluripotent cells. The
strength of this observation
derives from the different
methods bywhich each group
arrives at this conclusion.
Morey et al. utilized a
comparative genome-wide
chromatin-immunoprecipitat-
ion (ChIP-Seq) approach to
assay the binding of PRC1,
PRC2, and severalmethylated
histones. Coupled with
endogenous coimmunopreci-pitation (coIP), they demonstrate that
a 97% of Cbx7 binding sites are co-occu-
pied by PRC1, PRC2, of which 86% are
also marked by H3K27me3. Several of
thesesites areassociatedwithearly devel-
opmental genes which are known to be
repressed in pluripotent cells, including
the HOX cluster. O’Loghlen et al. take
a different approach, utilizing quantitative
proteomics to identify proteins which
interact directly with H3K27me3 in ESCs
versus differentiated cells. In pluripotent
cells, Cbx7 is the only Cbx protein found
to associate with H3K27me3, while in
differentiating cells and fibroblasts, Cbx2
and Cbx8 were the primary H3K27me3
interacting PCs, with no detectable Cbx7
interaction observed. This was the first
indication that the Cbx protein composi-
tion of PRC1 complexes may be dynami-
cally regulated in pluripotent versusdifferentiated cells, a phenomenon not
previously observed for PC orthologs in
pluripotent cells (Figure 1).
Further, ChIP with pluripotent cells
revealed strong association of Cbx7/
PRC1 localization to Cbx2, Cbx4, and
Cbx8, concomitant with transcriptional
repression of these genes (Morey et al.,
2012, and O’Loghlen et al., 2012).
Notably, both Cbx7 and PRC1 localization
to chromatin is completely dependent
on PRC2-mediated H3K27me3 (Morey
et al., 2012). This experiment provides
additional support to the idea that Cbx
proteins ‘‘read’’ the epigenome to identify
appropriate sites for PRC1-mediated
deposition of H2AK119Ub1 in pluripotent
cells. Transient and stably integrated
RNAi-mediated knockdown of Cbx7 in
ESCs (Morey et al., 2012; O’Loghlen




Cbx7 leads an increase
in several phenotypes asso-
ciated with self-renewal
(O’Loghlen et al., 2012).
These data strongly sug-
gest that the Cbx protein
composition of the PRC1
complex may be dynamically
altered in response to differ-
entiation and that Cbx7-asso-
ciated PRC1 is specific to
maintenance of self-renewal.
To test this possibility, both
groups performed a com-
bination of experiments to
examine PRC1 composition
and chromatin binding in
ESCs differentiated into em-
bryoid bodies (EBs). Morey
et al. performed ChIP and
coIP for Cbx2, Cbx4, and
Cbx7, while O’Loghlen et al.
examined localization of
Cbx8 by ChIP. Both groups
found that Cbx7 expression
decreased as ESCs differ-
entiated into EBs, while
expression of Cbx2, 4, and
8 concomitantly increased.
During differentiation into
EBs, PRC1 complexes bound
to chromatin were found to no
longer contain Cbx7, but
rather incorporated Cbx2 andCbx4 (Morey et al., 2012). Additionally,
O’Loghlen et al. observed that Cbx7 and
Cbx8 had reciprocal binding patterns at
promoters in ESCs versus differentiated
cells. Taken together these data point to
a dynamic mechanism by which the
PCR1 complex exchanges Cbx7 for
Cbx2, 4, or 8 during differentiation.
Building on these results, O’Loghlen
et al. sought to identify the mechanism
for Cbx7 downregulation upon differentia-
tion. Citing a recent study which identified
micro RNAs (miRs) as regulators of ESC
differentiation (Melton and Blelloch,
2010), the authors cleverly utilized a miR
expression library to identify two putative
miRs (miR-125, miR-181) which downre-
gulated a Cbx7-reporter construct.
When overexpressed in fibroblasts, these
miRs decreased Cbx7 transcript levels
and induced senescence, a phenotype6, 2012 ª2012 Elsevier Inc. 5
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ated knockdown of Cbx7 (Gil et al.,
2004). Strikingly, when expressed in
ESCs, miR-125 and miR-181 downregu-
lated Cbx7 expression and promoted
differentiation, providing direct evidence
that miR regulation of PcG proteins is
a determining factor in maintenance of
self-renewal in pluripotent cells.
In their final experiment Morey et al.
demonstrate that ESCs depleted of
Cbx7, Cbx4, and Cbx2 can form tera-
tomas in vivo. This was not entirely unex-
pected considering previous work has
shown that teratomas can be formed
even in the absence of PRC1 (Leeb et al.,
2010). The authors assert that the tera-
toma formation is skewed toward the
ectodermal lineage for grafts depleted of
Cbx7 and the endodermal and meso-
dermal lineage for grafts depleted Cbx2
and Cbx4. Although this in vivo data is
somewhat qualitative, it is consistent with
expression data from Cbx7, Cbx2, and
Cbx4 knockdowns. The role of the Cbx/
PRC1 complex specificity as it relates to6 Cell Stem Cell 10, January 6, 2012 ª2012 Edifferentiation into the three germs layers
needs to be further explored both in vitro
and in vivo. Another interesting question
not addressed in either paper is how PcG
complexes are regulated when differenti-
ated cells are returned to a pluripotent
state using iPS technology. It would be
interesting and informative to see if
Cbx7/PRC1 complexes are reformed
with a return to pluripotency and if these
complexes function to transcriptionally
re-repress Cbx2, 4, and 8. Nonetheless,
these reports mark a significant step
toward understanding how PcG proteins
are regulated in ESCsand how this regula-
tion helps modulate the fine balance
between self-renewal and differentiation
in pluripotent cells.REFERENCES
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Mesenchymal stem cells (MSCs) are a promising source for bone regeneration. Recently, inNature Medicine,
Liu et al. (2011) reported that host lymphocytes secrete IFN-g and TNF-a to initiate apoptosis of transplanted
MSCs and that aspirin can alleviate these effects to improve bone repair.The skeletal system provides unique
niches for maintaining a permanent he-
matopoietic stem cell (HSC) pool, from
which all cells of the immune system
derive, and for the differentiation and
maturation of immune cells. Osteoblasts,
which are derived from mesenchymal
stem cells (MSCs), and cells of the
myeloid lineages provide key factors forthe HSC microenvironment during devel-
opment and adulthood (Askmyr et al.,
2009). Lymphocytes are known to contin-
uously migrate through the bone marrow
but the precise physiology of this cell
traffic is poorly understood. It is, however,
well established that certain lymphocyte
subsets such as long-lived memory T
and B cells reside in specialized nichesin the bone marrow (Tokoyoda et al.,
2009). Defining cellular interactions be-
tween immune cells and the bone tissue
in which they reside is an important goal
of the newly emerging osteoimmunology
field, and such insights may also be help-
ful for designing improved protocols
for MSC-mediated bone repair and/or
regeneration.
